Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Pharmaceuticals Other
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| HZNP | Horizon Therapeutics Plc | 0.00% | 78.91 | 5.6% | $205.00m | |
| VRX | Valeant Pharmaceuticals International, Inc. | 0.00% | 26.41 | 14.1% | $155.40m | |
| CTLT | Catalent, Inc. | -0.26% | 115.00 | 2.1% | $113.43m | |
| BHC | Bausch Health Cos., Inc. | 0.00% | 26.41 | 0.0% | $90.94m | |
| JAZZ | Jazz Pharmaceuticals Plc | 0.00% | 165.81 | 2.4% | $87.34m | |
| UTHR | United Therapeutics Corp. | 0.00% | 167.26 | 14.1% | $64.76m | |
| SAGE | SAGE Therapeutics, Inc. | 0.90% | 97.63 | 7.6% | $58.81m | |
| ACST | Acasti Pharma, Inc. | 1.12% | 0.64 | 0.2% | $53.37m | |
| GWPH | GW Pharmaceuticals Plc | 1.37% | 139.72 | 6.1% | $49.06m | |
| AMRN | Amarin Corp. Plc | 0.16% | 6.14 | 1.5% | $47.57m | |
| PRGO | Perrigo Co. Plc | 0.16% | 44.72 | 6.8% | $47.42m | |
| ISR | IsoRay, Inc. | 6.84% | 2.03 | 2.5% | $46.22m | |
| ICLR | ICON plc | 0.00% | 210.66 | 4.2% | $42.89m | |
| PCRX | Pacira Biosciences, Inc. | 0.00% | 77.16 | 10.0% | $38.41m | |
| ENDP | Endo International Plc | 0.69% | 7.27 | 8.7% | $38.32m |
Company Profile
SAGE Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of novel medicines to treat life-altering central nervous system. Its programs include brexanolone, which is an acute interventional treatment for postpartum depression; and SAGE-217, an oral therapy for treatment of various CNS disorders. The company was founded by Steven Marc Paul and Douglas Covey in April 2010 and is headquartered in Cambridge, MA.